|
Additional fda product codes include: dqe- catheter, oximeter, fiber-optic, qaq- adjunctive predictive cardiovascular indicator, mud- oximeter, tissue saturation, dsb- plethysmograph, impedance, qms- adjunctive open loop fluid therapy recommender, fll- thermometer, electronic, clinical, dxn- system, measurement, blood-pressure, non-invasive, olw- index-generating electroencephalograph software.The device evaluation is anticipated.However, the complaint cannot be confirmed without the completion of a product evaluation.A supplemental report will be forthcoming when the investigation is completed.
|
|
One hemosphere clearsight module was returned for evaluation.The customer report of inaccurate values was not able to be confirmed.The clearsight module was connected to a known working hemosphere monitor hot mock-up system.The module caused no errors.It was also able to obtain normal blood pressure readings and waveform.During1 hour of monitoring, the blood pressure readings remained stable for the duration.No damage was found on the device.The device history record review was completed and the product passed without nonconformances.An engineering evaluation was initiated to assess for any manufacturing related processes which could be correlated to the complaint.As the device was returned and no defect was found, a product non-conformance or device failure associated to manufacturing or design could be confirmed.The instructions for use include the following cautions: inaccurate measurements can be caused by excessive variations in blood pressure, poor blood circulation in fingers, excessive patient movement, incorrect placement of finger cuff, or a bent cuff.
|